Nanotechnology Now - News Story: DuPont joint venture takes pre-emptive first strike in nano legal dispute

Home > News > DuPont joint venture takes pre-emptive first strike in nano legal dispute

January 3rd, 2007

DuPont joint venture takes pre-emptive first strike in nano legal dispute

Abstract:
In what may become an increasingly familiar byproduct of nanotech commercialization, a joint venture involving chemical giant DuPont has sued a supplier of a nanotech product used in semiconductor manufacture over a patent license.

Source:
smalltimes.com

Bookmark:

Related News Press

Chip Technology

Metasurfaces smooth light to boost magnetic sensing precision January 30th, 2026

Beyond silicon: Electronics at the scale of a single molecule January 30th, 2026

Researchers demonstrates substrate design principles for scalable superconducting quantum materials: NYU Tandon–Brookhaven National Laboratory study shows that crystalline hafnium oxide substrates offer guidelines for stabilizing the superconducting phase October 3rd, 2025

Lab to industry: InSe wafer-scale breakthrough for future electronics August 8th, 2025

Announcements

Decoding hydrogen‑bond network of electrolyte for cryogenic durable aqueous zinc‑ion batteries January 30th, 2026

COF scaffold membrane with gate‑lane nanostructure for efficient Li+/Mg2+ separation January 30th, 2026

Breathing new life into nanotubes for a cooler planet:Researchers at Skoltech discover a simple, single-step heat treatment that nearly doubles the CO2-trapping power of carbon nanotubes January 30th, 2026

New light-based nanotechnology could enable more precise, less harmful cancer treatment: The approach offers a potential alternative to chemotherapy and radiation by using light and heat to target cancer cells. January 30th, 2026

Patents/IP/Tech Transfer/Licensing

Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023

Study finds nanomedicine targeting lymph nodes key to triple negative breast cancer treatment: In mice, nanomedicine can remodel the immune microenvironment in lymph node and tumor tissue for long-term remission and lung tumor elimination in this form of metastasized breast cance May 13th, 2022

Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021

Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020



Premium Products


	Only the news you want to read! Learn More



	Full-service, expert consulting Learn More




	The latest news from around the world, FREE